Although BRCA1 and BRCA2-specific genetic testing is rapidly evolving in the clinical setting, mutations in these genes are successful at explaining only around half of the dominant multi-case breast cancer only families [4], and their contribution to the heritable risk of breast cancer has been estimated to be no more than around 20% of the total [5], [6]. This evidence concerns the gene BRCA1 and breast cancer.